Skip to main content
. 2018 Oct 3;41(12):2544–2551. doi: 10.2337/dc18-1662

Table 1.

Demographic, physical, and metabolic characteristics of study participants at baseline for all randomized participants and for participants who completed 24-month testing*

Randomized
Completed 24 months testing
Gastric band (N = 44) Metformin (N = 44) P value Gastric band (N = 36) Metformin (N = 34) P value Interaction P value
Demographics







 Female
34 (77)
35 (79)
0.80
29 (81)
27 (79)
0.90
0.60
 Age (years)
47 ± 10
51 ± 9
0.14
47 ± 10
52 ± 9
0.03
0.10
 Race/ethnicity


0.68


0.98
0.96
 White
15 (34)
10 (23)

9 (25)
9 (26)


 Black
7 (16)
9 (20)

7 (20)
7 (21)


 Hispanic
19 (43)
21 (48)

17 (47)
16 (47)


 Asian
3 (7)
4 (9)

3 (8)
2 (6)


Anthropometrics







 Weight (kg)
97.5 ± 12.2
96.1 ± 10.9
0.57
97.0 ± 12.2
95.9 ± 10.5
0.68
0.86
 BMI (kg/m2)
35.7 ± 2.9
35 ± 2.9
0.24
35.7 ± 2.9
34.8 ± 2.8
0.24
0.89
Glucose status







 IGT
25 (57)
26 (59)
0.83
18 (50)
20 (59)
0.46
0.10
 Diabetes
19 (43)
18 (41)
0.83
18 (50)
14 (42)
0.46

 Fasting glucose (mmol/L)
6.2 ± 0.7
6.2 ± 0.8
0.88
6.2 ± 0.8
6.2 ± 0.9
0.69
0.57
 2-h glucose (mmol/L)
10.4 ± 2.7
10.5 ± 2.6
0.78
10.6 ± 2.7
10.5 ± 2.5
0.89
0.44
 HbA1c (mmol/mol) 41.2 ± 4.6 40.1 ± 4.5 0.28 41.5 ± 4.5 40.8 ± 4.6 0.52 0.33

*Data are mean ± SD for continuous variables or n (%) for categorical variables.

†Interaction P value testing for differential effect of loss to follow-up between groups.